These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 4279519)

  • 1. Immunological deviation between a transplantable tumor and its artificially converted ascitic variant.
    Tokuzen R; Nakahara W
    Z Krebsforsch Klin Onkol Cancer Res Clin Oncol; 1974; 81(3-4):235-8. PubMed ID: 4279519
    [No Abstract]   [Full Text] [Related]  

  • 2. Inhibitory effect of polyinosinic:polycytidylic acid on the growth of transplantable mouse mammary carcinoma.
    Potmesil M; Goldfeder A
    Proc Soc Exp Biol Med; 1972 Apr; 139(4):1392-7. PubMed ID: 5023340
    [No Abstract]   [Full Text] [Related]  

  • 3. Suppression of autochthonous grafts of spontaneous mammary tumor by induced allogeneic graft rejection mechanism.
    Tokuzen R; Nakahara W
    Cancer Res; 1973 Apr; 33(4):645-7. PubMed ID: 4696465
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of ethidium bromide against transplantable tumors in mice and rats.
    Kramer MJ; Grunberg E
    Chemotherapy; 1973 Oct; 19(4):254-8. PubMed ID: 4801160
    [No Abstract]   [Full Text] [Related]  

  • 5. Discussion paper: the immune status of the murine host bearing transplantable syngeneic growing tumors.
    Manson LA
    Ann N Y Acad Sci; 1976; 276():272-5. PubMed ID: 829206
    [No Abstract]   [Full Text] [Related]  

  • 6. Chemotherapy of transplantable adenocarcinomas of the colon in mice. II. Development and characterization of an ascitic line.
    Double JA; de Castro LC
    Cancer Treat Rep; 1978 Jan; 62(1):85-90. PubMed ID: 626999
    [No Abstract]   [Full Text] [Related]  

  • 7. Tumor immunity and the mechanism of polyinosinic-polycytidylic acid inhibition of tumor growth.
    Kreider JW; Benjamin SA
    J Natl Cancer Inst; 1972 Nov; 49(5):1303-10. PubMed ID: 4568087
    [No Abstract]   [Full Text] [Related]  

  • 8. Cyclophosphamide-adriamycin combination chemotherapy of transplantable murine tumors.
    Corbett TH; Griswold DP; Mayo JG; Laster WR; Schabel FM
    Cancer Res; 1975 Jun; 35(6):1568-73. PubMed ID: 1131824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploratory studies of vitamin A and cyclophosphamide in tumor-bearing mice.
    Nathanson L; Maddock CL; Hall TC
    J Clin Pharmacol J New Drugs; 1969; 9(6):359-73. PubMed ID: 5260199
    [No Abstract]   [Full Text] [Related]  

  • 10. [Immunological tumor--host relationships in mice].
    Müller M; Welcker ER; Schlotterhoss I; Henker J
    Allerg Asthma (Leipz); 1969; 15(3):157-62. PubMed ID: 4906036
    [No Abstract]   [Full Text] [Related]  

  • 11. [Antitumor activity of Basidiomycetes].
    Ito H; Naruse S; Fujii K
    Nihon Yakurigaku Zasshi; 1972 Jul; 68(4):429-41. PubMed ID: 4676299
    [No Abstract]   [Full Text] [Related]  

  • 12. Accelerated growth of mammary tumor cells in normal and athymic mice after treatment in vitro with dexamethasone.
    Gillette RW; Wunderlich DA
    Cancer Res; 1978 Oct; 38(10):3146-9. PubMed ID: 80260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies on the antitumor activity of polysaccharides from Flammulina velutipes (Curt. ex Fr.) Sing.
    Ikekawa T; Yoshioka Y; Emori M; Sano T; Fukuoka F
    Cancer Chemother Rep; 1973 Feb; 57(1):85-6. PubMed ID: 4735779
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparative immunotherapeutic effect of concanavalin A and neuraminidase-treated cancer cells.
    Simmons RL; Rios A
    Transplant Proc; 1975 Jun; 7(2):247-51. PubMed ID: 1129845
    [No Abstract]   [Full Text] [Related]  

  • 15. Immunologic control of the ascites of murine adenocarcinoma 755. I. Protection with syngeneic immune serum or lymphoid cells.
    Haagensen DE; Roloson G; Collins JJ; Wells SA; Bolognesi DP; Hansen HJ
    J Natl Cancer Inst; 1978 Jan; 60(1):131-9. PubMed ID: 628013
    [No Abstract]   [Full Text] [Related]  

  • 16. Screening data from the Cancer Chemotherapy National Service Center Screening Laboratories. XLI. Plant extracts.
    Abbott BJ; Hartwell JL; Leiter J; Spetzman LA; Schepartz SA
    Cancer Res; 1967 May; 27(5 Pt 2):364-527. PubMed ID: 4290629
    [No Abstract]   [Full Text] [Related]  

  • 17. Immunological analysis of A strain mice bearing the A-10 mammary adenocarcinoma.
    Tax A; Manson LA
    Cancer Res; 1979 May; 39(5):1739-47. PubMed ID: 85488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induced alteration of resistance to transplantable mammary adenocarcinoma in mice neonatally inoculated with rat thymus antiserum.
    Anigstein L; Anigstein DM; Rennels EG; O'Steen WK
    Cancer Res; 1966 Sep; 26(9):1867-72. PubMed ID: 5924952
    [No Abstract]   [Full Text] [Related]  

  • 19. Synergism between host anti-tumor immunity and combined modality therapy against murine breast cancer.
    Stolfi RL; Fugmann RA; Stolfi LM; Martin DS
    Int J Cancer; 1974 Mar; 13(3):389-403. PubMed ID: 4822108
    [No Abstract]   [Full Text] [Related]  

  • 20. Resistance to a transplantable rat mammary tumor (DMBA 8BT) after pre-treatment with syngeneic fetal cells.
    Cocuzzi E; Kellen JA
    Res Commun Chem Pathol Pharmacol; 1978 May; 20(2):405-8. PubMed ID: 674823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.